Session 39-Oral Abstracts
Cancer and HIV: Treatment, Pathogenesis, and Risk Factors
Thursday, 10 am-12 noon; Room 6D
10:00 am      129 HIV and Cancer
Ariela Noy
Memorial Sloan-Kettering Cancer Ctr, New York, NY, US
10:30 am      130 NADM and Immunosuppression: The D:A:D Study
Signe Worm on behalf of the D:A:D Study Group
Copenhagen HIV Prgm, Denmark
10:45 am      131 Incidence and Predictors of NHL among HIV+ Patients on Suppressive ART
Chad Achenbach*1, S Cole2, J Kahn3, M Mugavero4, H Crane5, J Eron2, R Moore6, R Haubrich7, M Saag4, and M Kitahata5
1Northwestern Univ, Chicago, IL, US; 2Univ of North Carolina at Chapel Hill, US; 3Univ of California, San Francisco, US; 4Univ of Alabama at Birmingham, US; 5Univ of Washington, Seattle, US; 6Johns Hopkins Univ, Baltimore, MD, US; and 7Univ of California, San Diego, US
11:00 am  132LB EBV+ Diffuse Large B cell Lymphomas in HIV+ Individuals Are Frequently Non-germinal B Cell Type, Usually Devoid of Common Translocations, and Predict Poor Survival
Kishor Bhatia*1, C Chang1, W Cozen2, L Weiss3, C Kim1, L Morton1, and E Engels1
1NCI, NIH, Rockville, MD, US; 2Univ of Southern California, Keck Sch of Med and Norris Comprehensive Cancer Ctr, Los Angeles, US; and 3City of Hope Natl Med Ctr, Duarte, CA, US
11:15 am      133 Incidence and Risk Factors for Oral Cancer among HIV+ Individuals: North America
Alison Abraham*1, Y Jing1, D Beachler1, M Silverberg2, J Gill3, R Dubrow4, M Kitahata5, M Klein6, R Moore7, G D’Souza1, and North American AIDS Cohort Collaboration on Res and Design (NA-ACCORD) of IeDEA
1Johns Hopkins Univ Bloomberg Sch of Publ Hlth, Baltimore, MD, US; 2Kaiser Permanente Northern California, Oakland, US; 3Univ of Calgary, Canada; 4Yale Univ Sch of Publ Hlth, New Haven, CT, US; 5Univ of Washington, Seattle, US; 6McGill Univ, Montreal, Canada; and 7Johns Hopkins Univ Sch of Med, Baltimore, MD, US
11:30 am      134 Prospective Evaluation of the Impact of ART on the Incidence of KS—IeDEA Consortium: East Africa
Jeffrey Martin*1, M Wenger1, N Busakhala2, N Buziba2, M Bwana3, W Muyindike3, E Amerson1, C Yiannoutsos4, B Musick4, K Wools-Kaloustian4, and East Africa Intl Epidemiologic Databases to Evaluate AIDS (IeDEA) Consortium
1Univ of California, San Francisco, US; 2Moi Univ, Eldoret, Kenya; 3Mbarara Univ of Sci and Tech, Uganda; and 4Indiana Univ, Indianapolis, US
11:45 am  135LB Treatment of Anal Intraepithelial Neoplasia in HIV+ MSM: A Triple-arm Randomized Clinical Trial of Imiquimod, Topical 5-Fluoruracil, and Electrocautery
Olivier Richel*, H De Vries, C Van Noesel, M Dijkgraaf, and J Prins
Academic Med Ctr, Amsterdam, The Netherlands